Apr.

New published research paper: Biobran/MGN-3, an Arabinoxylan Rice Bran, Exerts Anti-COVID-19 Effects and Boosts Immunity in Human Subjects

Feb.

Academic presentation: The 7th International Multidisciplinary Breast Conference (UAE)

Feb.

Book on BioBran Published

Feb.

New published research paper: Rice Bran Arabinoxylan Compound and Quality of Life (RBAC-QoL) of Cancer Patients: An Interim Analysis of the RBAC-QoL Study

Oct.

Exhibition: Pet Fair South East Asia 2023

Oct.

New published research paper: Modified Rice Bran Arabinoxylan by Lentinus edodes Mycelial Enzyme as an Immunoceutical for Health and Aging-A Comprehensive Literature Review”

Oct.

New published research paper: Modified rice bran arabinoxylan as a nutraceutical in health and disease—A scoping review with bibliometric analysis

Oct.

New published research paper:” Changes in the Human Gut Microbiome during Dietary Supplementation with Modified Rice Bran Arabinoxylan Compound”

Oct.

New published research paper: “Effects of Dietary Bacillus natto Productive Protein on the Skin: In Vitro Efficacy Test and Single-Armed Trial”

Oct.

Exhibition: Vitafoods Asia 2023

Sep.

Webinar for Daiwa’s business partners

Feb.

New published research paper: “Biobran/MGN-3, an Arabinoxylan Rice Bran, Protects against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An In Vitro and In Silico Study”

Dec.

Webinar for Daiwa’s business partners

Nov.

Exhibition: Vitafoods Asia 2022

Nov.

New published research paper: “The Natural Killer Cell in Anticancer Therapy – An Important Role for Natural Compounds“

Oct.

Exhibition: Vitafoods Asia 2022

Aug.

New published research paper: “Enhancing effect of streptozotocin-induced insulin deficit on antitumor innate immune defense in rats“

Aug.

Webinar for Daiwa’s business partners

Jul.

Webinar for Daiwa’s business partners

May.

New published research paper: “Effects of Bacillus subtilis Var. Natto Products on Capillary Blood Flow in Healthy Subjects with Peripheral Coldness: A Double-Blind, Placebo-Controlled, Randomized Parallel Study”

May.

New published research paper: Dietary Supplementation with Biobran/MGN-3 Increases Innate Resistance and Reduces the Incidence of Influenza-like Illnesses in Elderly Subjects: A Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial

May.

New published research paper: RBAC and Its Role with the Immune System

May.

New published research paper: KDP, a Lactobacilli Product from Kimchi, Enhances Mucosal Immunity by Increasing Secretory IgA in Mice and Exhibits Antimicrobial Activity

May.

Exhibition: NATURAL PRDODUCT EXPO WEST 2022 (DHD USA)

May.

Exhibition: Integrative Healthcare Symposium (DHD USA)

Aug.

An interview article with Dr. Serge Jurasunas on Immuno- Oncology

Aug.

Newly published book on BioBran

Aug.

Webinar for Daiwa’s overseas business partners

Jun.

Webinar for Daiwa’s overseas business partners

Jun.

Training session for Daiwa’s business partners in Japan (Webinar)

Jun.

The Distributors’ Meeting (DHD Europe)

May.

New published research paper: Preparation of a saliva- active toothpaste

May.

New published research paper: Effect of rice bran arabinoxylan on immunity

May.

New published research paper: BioBran, Immuno Modulating Rice Bran Arabinoxylan Compound: Functions and Evidence

Dec.

New published research paper: Can standardized and evidence- based plant immunomodulator (rice bran arabinoxylan concentrate) increase the effect of Gemcitabine in a synergistic manner? Case report of a patient with ductal pancreas carcinoma

Dec.

Website updated: Daiwa’ efforts to support SDGs

Dec.

New Essay Series: “What is prime aging?”

Dec.

New published research paper: A Functional Food for Metabolic Disorders

Nov.

Training session for Daiwa’s business partners (Indonesia)

Nov.

Webinar on BioBran (Bangladesh)

Aug.

Training session for Daiwa’s business partners (Webinar)

Jun.

Webinar on BioBran (Bangladesh)

Jun.

Daiwa supports SDGs (The Sustainable Development) Project

Jun.

New Essay Series: “Infectious Diseases and Immunity”

Jun.

New published research paper: Chemopreventive role of arabinoxylan rice bran, MGN-3/Biobran, on liver carcinogenesis in rats

Jun.

New published research paper: Arabinoxylan rice bran (MGN-3/Biobran) enhances radiotherapy in animals bearing Ehrlich ascites carcinoma

Jun.

New published research paper: Arabinoxylan rice bran (MGN-3/Biobran) alleviates radiation-induced intestinal barrier dysfunction of mice in a mitochondrion-dependent manner

Mar.

Exhibition: Get Well Show 2020 (UK)

Mar.

New published research paper: The Immunomodulating Effects of Arabinoxylan Rice Bran on Hematologic Profile, Nutritional Status and Quality of Life among Head and Neck Carcinoma Patients Undergoing Random Therapy: A Double Blind Randomized Control Trial

Mar.

BioBran Workshop (Bangladesh)

Jan.

Training session for Daiwa’s business partners (Osaka)

Jan.

Training session for Daiwa’s business partners (Tokyo)

Dec.

Exhibition: AONM International Conference 2019

Dec.

BioBran attracted great attention at ANP in the UK

Nov.

“Medical Week Baden-Baden” (Germany)

Oct.

BioBran Workshop (Singapore)

Oct.

Exhibition: Vitafoods Asia 2019

Jun.

New published research paper: Fermented product of rice with Lactobacillus kefiranofaciens induces anti-aging effects and heat stress tolerance in nematodes via DAF-16

Jun.

The 30th Training session for Daiwa’s business partners (Tokyo)

Jun.

The 29th Training session for Daiwa’s business partners (Osaka)

Apr.

Academic Presentation: International Annual Conference on EACR (Egyptian Association for Cancer Research)

Apr.

Exhibition: Health Food Expo, Ingredients and Contract Manufacture 2019

Apr.

Training Session for a business partner in Australia

Apr.

Exhibition: NATURAL PRODUCTS EXPO WEST 2019 (DHD USA)

Mar.

Training Session for a business partner in Bangladesh

Jan.

Training session for Daiwa’s business partners (Tokyo)

Jan.

Training session for Daiwa’s business partners (Osaka)

Dec.

Academic Presentation: China cancer society cancer support treatment committee 2018 academic annual conference

Nov.

Academic presentation: Integrative Oncology (Germany)

Nov.

BSAA: BSAAM 15th Annual Anti- Ageing Conference (U.K.)

Oct.

New published research paper: New Perspectives to Improve the MHC-I Unrestricted Immune Mechanisms against Malignant Tumors

Oct.

Wellness Seminar: NKCP was introduced

Oct.

Partnerships establishment with a pharmaceutical company in Bangladesh

Oct.

Training Session for a business partner in Bangladesh

Oct.

Exhibition: Vitafoods Asia 2018

Jul.

New published research paper: The Effect of a Hydrolyzed Polysaccharide Dietary Supplement on Biomarkers in Adults with Nonalcoholic Fatty Liver Disease

Jul.

BioBran International Workshop 2018

May.

Exhibition: NATURAL PRDODUCT EXPO WEST 2018 (DHD USA)

Apr.

Tsukuba Plant certified to FSSC22000

Apr.

Academic presentation by Daiwa’s business partner in Croatia

Apr.

New published research paper: Effects of products containing Bacillus subtilis var. natto on healthy subjects with neck and shoulder stiffness, a double-blind, placebo-controlled, randomized crossover study

Dec.

Training session for Daiwa’s business partners

Dec.

New published research paper: “Urgent Necessity for Standardized and Evidence Based Plant Immunomodulators (Such As Rice Bran Arabinoxylan Concentrate/MGN-3) for the Tumor Research”

Nov.

New published research paper: “Evidence-Based Review of BioBran/MGN-3 Arabinoxylan Compound as a Complementary Therapy for Conventional Cancer Treatment”

Nov.

New published research paper: “Can a standardized plant immunomodulator (rice bran arabinoxylan concentrate/MGN-3) increase the effects of MEK and BRAF inhibitors with clinical benefit? Case report of a patient with carcinoma in biliary duct”

Nov.

Exhibition: Supply Side West 2017 (DHD USA)

Sep.

Academic Presentation: The 9th A4M Thailand Congress on Anti-Aging and Aesthetics Medicine

Sep.

NKCP International Workshop

Sep.

Exhibition: Vitafoods Asia 2017

Sep.

Exhibition: “Medipharm Expo 2017”

Jul.

New Published Research Paper: Controlled pilot study for cancer patients suffering from chronic fatigue syndrome due to chemotherapy treated with BioBran (MGN-3 Arabinoxylane) and targeted radiofrequency heat therapy

Jul.

BioBran Workshop 2017 (DHD Europe)

Jun.

Training Session for a business partner in Canada　(DHD USA)

Jun.

Training session for Daiwa’s business partners

May.

New Published Research Paper: Modified rice bran hemicellulose inhibits vascular endothelial growth factor-induced angiogenesis in vitro via VEGFR2 and its downstream signaling pathways

Apr.

Exhibition: Health Food Expo, Ingredients and Contract Manufacture 2017

Mar.

Awarded with “Rising Small and Medium Enterprises 300 in 2017”

Mar.

Exhibition: NATURAL PRDODUCT EXPO WEST 2017 (DHD USA)

Mar.

New published research paper: Arabinoxylan rice bran (Biobran) suppresses the viremia level in patients with chronic HCV infection: A randomized trial

Mar.

New Essay Series: “Food, Nutrition, and Exercise for Healthy Living”

Feb.

Training Session for a business partner in the USA　(DHD USA)

Jan.

New published research paper: From Bench to Bedside: The Growing Use of Arabinoxylan Rice Bran (MGN-3/Biobran) in Cancer Immunotherapy

Jan.

Training session for Daiwa’s business partners in the Tokyo area

Dec.

BioBran International Workshop (Taiwan)

Dec.

Exhibition: Society for Integrative Oncology (DHD USA)

Nov.

International Oncology Support Summit (Australia)

Nov.

Exhibition: Supply Side West 2016 (DHD USA)

Oct.

Exhibition: CHFA EAST (DHD USA)

Sep.

Exhibition: Vitafoods Asia 2016 (Hong Kong)

Aug.

BioBran Seminar 2016

Aug.

Exhibition: The 25th China (Guangzhou) International Health Industry Expo 2016

Jul.

The Threshold Tabletop Show (DHD USA)

Jul.

New published research paper: Can the EGFR inhibitors increase the immunomodulatory effects of standardized plant extracts (mistletoe lectin and arabinoxylan) with clinical benefit? Case report of a patient with lung adenocarcinoma

Jul.

New published research paper: Addition of Rice Bran Arabinoxylan to Curcumin Therapy May Be of Benefit to Patients With Early-Stage B-Cell Lymphoid Malignancies (Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Stage 0/1 Chronic Lymphocytic Leukemia):A Preliminary Clinical Study

Jul.

Training session for Daiwa’s business partner in Kansai region

Jul.

Training session for Daiwa’s business partners in the Tokyo area

Jun.

Academic Presentation: Prevention of hepatocarcinogenesis in rats by arabinoxylan rice bran, MGN-3/Biobran

Jun.

New Published Research Paper: Chemopreventive Activity of MGN-3/Biobran Against Chemical Induction of Glandular Stomach Carcinogenesis in Rats and Its Apoptotic Effect in Gastric Cancer Cells

May.

Oncology Days 2016 (Czech Republic)

May.

New Published Research Paper: Improvement of Quality of Life in Tumor Patients after an Immunomodulatory Treatment with Standardized Mistletoe Lectin and Arabinoxylan Plant Extracts

Apr.

Exhibition: Health Food Expo, Ingredients and Contract Manufacture 2016

Apr.

Exhibition: NATURAL PRODUCT EXPO WEST 2016 (DHD USA)

Mar.

Presentation by Prof. Egashira at ACS

Mar.

Exhibition: Gulfood 2016

Mar.

BioBran Seminar for Indonesian Medical Practitioners

Nov.

The 31th Congress of Hungarian Cancer Society (Hungary)

Nov.

BioBran seminar for doctors from Philippines

Nov.

New Published Research Paper: Can a synergistic activation of pattern recognition receptors by plant immunomodulators enhance the effect of oncologic therapy? Case Report of a patient with uterus and ovary sarcoma

Nov.

Intensive Workshop Integrative Oncology (Germany)

Nov.

Training session for Daiwa’s business partners in the Tokyo area

Oct.

Exhibition: Supply Side West 2015

Sep.

Exhibition: Vitafoods Asia

Aug.

Exhibition: 2015 Bio Taiwan Exhibition

Aug.

JDF award to Prof. Egashira (Chiba University), research on rice bran arabinoxylan

Jul.

Academic Presentation: Food Beyond Science and Technology (Korea)

Jul.

Training session for Daiwa’s business partners in the Tokyo area

Jun.

Training session for Daiwa’s business partner in Kansai region

Jun.

SEKCAMA 20th International Conference of Breast Carcinoma in Slovakia

May.

Daiwa’s business partner in Hungary participated in Integrative Medicine Congress

May.

Exhibition: Health Food Expo, Ingredients and Contract Manufacture 2015

May.

Exhibition: CAM Expo Dusseldorf (Germany)

Apr.

Academic Presentation: BioBran/MGN-3, arabinoxylan from rice bran, sensitizes breast adenocarcinoma tumor cells to paclitaxel in mice

Apr.

BioBran Seminar for Indonesian Medical Practitioners

Apr.

Exhibition: NATURAL PRODUCT EXPO WEST 2015 (DHD USA)

Mar.

Daiwa’s business partner in Hungary participated in Oncology Symposium

Mar.

Daiwa’s business partner in Luxembourg organized a conference for onco- gynecologists

Mar.

Daiwa’s business partner in Czech exhibited at ONCO 2015 in Prague

Feb.

New Published Research Paper: Effects of Bacillus subtilis var. natto products on symptoms caused by blood flow disturbance in female patients with lifestyle diseases

Feb.

New Published Research Paper: MGN-3/BioBran enhances generation of cytotoxic CD8+ T cells via upregulation of DEC-205 expression on dendritic cells

Jan.

New Published Research Paper: Arabinoxylan rice bran (MGN-3/Biobran) enhances natural killer cell-mediated cytotoxicity against neuroblastoma, in vitro and in vivo

Jan.

Exhibition: The Annual World Congress of the American Academy of Anti-aging Medicine 2014 (DHD USA)

Dec.

Exhibition: The Annual Meeting of Japan Kampo Society

Dec.

Training session on NKCP for Daiwa’s business partner in Kansai region

Nov.

Exhibition: Supply Side West 2014 (DHD USA)

Nov.

Training session on BioBran for Daiwa’s business partner in Malaysia

Oct.

Anti-Aging Medicine, Asian Congress (AMAC) in Singapore

Oct.

Subsidy granted for the development of functional food ingredient

Sep.

Exhibition: Vitafoods Asia

Sep.

Renewal certificate for ISO9001:2008

Aug.

New Published Research Paper: Therapeutic Effects of BioBran, Modified Arabinoxylan Rice Bran, in Improving Symptoms of Diarrhea Predominant or Mixed Type Irritable Bowel Syndrome: A Pilot, Randomized Controlled Study

May.

Exhibition: Health Food Expo, Ingredients and Contract Manufacturing 2014

Apr.

BioBran International Workshop 2014

Apr.

Exhibition: NATURAL PRODUCT EXPO WEST 2014 (DHD USA)

Mar.

New published research paper: Effects of Bacillus Natto Products on Blood Pressure in Patients with Lifestyle Diseases

Feb.

Newly Registered BioBran Patent

Jan.

Newly published research paper: Modified Arabinoxylan from Rice Bran, known as MGN-3/ BioBran, Sensitizes Metastatic Breast Cancer Cells to Paclitaxel In Vitro

Dec.

Exhibition: Supply Side West 2013 (DHD USA)

Oct.

Subsidy from the Small and Medium Enterprise Agency for the Development of a New Functional Food Material

Oct.

Daiwa’s Taiwan distributors visited Tsukuba Plant

Oct.

Exhibition: Vitafoods Asia

Sep.

New Published Research Paper: Case Reports of Cancer Patients with Hepatic Metastases Treated by Standardized Plant Immunomodulatory Preparations

Aug.

Exhibition: “Bio Taiwan 2013”

Jun.

Daiwa Authorized Project based on “Collaboration of Primary, Secondary, and Tertiary Industry Act” by MAFF

Jun.

2nd Edition of BioBran Blue Book

Jun.

Official Website Renewal

Apr.

Exhibition: Health Food Expo, Ingredients and Contract Manufacture 2013

Mar.

BioBran Seminar for Indonesian Medical Practitioners

Mar.

Exhibition: 2013 Integrative Healthcare Symposium (DHD USA)

Feb.

New Published Research Paper: Protective effect of low molecular fraction of MGN-3, a modified arabinoxylan from rice bran, on acute liver injury by inhibition of NF-κB and JNK/MAPK expression

Feb.

NKCP Workshop 2013

Feb.

New Published Research Paper: Suppressive Effect of Modified Arabinoxylan from Rice Bran (MGN-3) on D-Galactosamine- Induced IL-18 Expression and Hepatitis in Rats

Jan.

Cancer in the Philippines (Daiwa’s Philippines Distributor)

Jan.

New Published Research Paper: Arabinoxylan rice bran (MGN-3/Biobran) provides protection against whole-body γ-irradiation in mice via restoration of hematopoietic tissues